BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32895393)

  • 1. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.
    Enotarpi J; Tontini M; Balocchi C; van der Es D; Auberger L; Balducci E; Carboni F; Proietti D; Casini D; Filippov DV; Overkleeft HS; van der Marel GA; Colombo C; Romano MR; Berti F; Costantino P; Codeé JDC; Lay L; Adamo R
    Nat Commun; 2020 Sep; 11(1):4434. PubMed ID: 32895393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A.
    Torres-Sanchez MI; Zaccaria C; Buzzi B; Miglio G; Lombardi G; Polito L; Russo G; Lay L
    Chemistry; 2007; 13(23):6623-35. PubMed ID: 17508372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.
    Menéndez T; Carmenate T; Cruz-Leal Y; Coizeau E; Caballero E; Bello D; Guirola M; Alvarez A; Guillén G
    Curr Microbiol; 2010 Feb; 60(2):79-84. PubMed ID: 19771476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a protective epitope reveals the importance of acetylation of
    Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoactivity of protein conjugates of carba analogues from Neisseria meningitidis a capsular polysaccharide.
    Gao Q; Tontini M; Brogioni G; Nilo A; Filippini S; Harfouche C; Polito L; Romano MR; Costantino P; Berti F; Adamo R; Lay L
    ACS Chem Biol; 2013 Nov; 8(11):2561-7. PubMed ID: 24000773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a synthetic glycoconjugate vaccine against Neisseria meningitidis A.
    Berkin A; Coxon B; Pozsgay V
    Chemistry; 2002 Oct; 8(19):4424-33. PubMed ID: 12355530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.
    Jin Z; Bohach GA; Shiloach J; Norris SE; Freedberg DI; Deobald C; Coxon B; Robbins JB; Schneerson R
    Infect Immun; 2005 Dec; 73(12):7887-93. PubMed ID: 16299279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and mechanistic basis of capsule O-acetylation in Neisseria meningitidis serogroup A.
    Fiebig T; Cramer JT; Bethe A; Baruch P; Curth U; Führing JI; Buettner FFR; Vogel U; Schubert M; Fedorov R; Mühlenhoff M
    Nat Commun; 2020 Sep; 11(1):4723. PubMed ID: 32948778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.
    Harris SL; Finn A; Granoff DM
    Infect Immun; 2003 Jun; 71(6):3402-8. PubMed ID: 12761124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary biological evaluation of carba analogues from Neisseria meningitidis A capsular polysaccharide.
    Gao Q; Zaccaria C; Tontini M; Poletti L; Costantino P; Lay L
    Org Biomol Chem; 2012 Sep; 10(33):6673-81. PubMed ID: 22850927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease.
    Adamo R; Nilo A; Harfouche C; Brogioni B; Pecetta S; Brogioni G; Balducci E; Pinto V; Filippini S; Mori E; Tontini M; Romano MR; Costantino P; Berti F
    Glycoconj J; 2014 Dec; 31(9):637-47. PubMed ID: 25256065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase.
    Gudlavalleti SK; Datta AK; Tzeng YL; Noble C; Carlson RW; Stephens DS
    J Biol Chem; 2004 Oct; 279(41):42765-73. PubMed ID: 15294916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development.
    Hlozek J; Ravenscroft N; Kuttel MM
    Carbohydr Res; 2019 Dec; 486():107838. PubMed ID: 31654945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo determination of Neisseria meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR spectroscopy.
    Gudlavalleti SK; Szymanski CM; Jarrell HC; Stephens DS
    Carbohydr Res; 2006 Mar; 341(4):557-62. PubMed ID: 16406275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
    Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
    Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
    Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
    Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.
    Pajon R; Fergus AM; Granoff DM
    PLoS One; 2013; 8(6):e66536. PubMed ID: 23805230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.